PATENT CLAIM ANALYSIS

Application Number: 16033038
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-03
Patent Classification: ["544", "236000"]

Abstract:
The present invention provides protein kinase having one of the following structures (I), (II) or (III): or a stereoisomer, prodrug, tautomer or pharmaceutically acceptable salt thereof, wherein R, R 1 , R 2  and X are as defined herein. Compositions and methods for using the same in the treatment of cancer, autoimmune, inflammatory and other Pim kinase-associated conditions are also disclosed.

Claim (Index 52):
The method of  claim 49 , wherein the solid tumor is non-small-cell lung cancer, oat-cell cancer, dermatofibrosarcoma protuberans, cutaneous melanoma, neoplastic cutaneous disease, intraocular melanoma, uterine sarcoma, carcinoma of the endometrium, carcinoma of the vagina, carcinoma of the cervix, carcinoma of the vulva, carcinoma of the fallopian tubes, colon cancer, anal region cancer, Barrett's esophagus, renal cell carcinoma, carcinoma of the renal pelvis, benign prostatic hypertrophy, parathyroid cancer, adrenal gland cancer, thyroid cancer, pituitary adenoma, primary central nervous system lymphoma, brain stem glioma, spinal axis tumor, or medulloblastoma.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 95.0
- Lexical Diversity: 1.4
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15207224', '14795123', '15353312', '15017394', '15373923']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7948731567810557
- 35 USC 102 Novelty (BERT): 0.5464384305270963
- Combined Prediction Score: 0.7700296841556599
- Mean Citation Score: 313.8797800000001
- Max Citation Score: 392.47394
- Similarity Product: 312.95984173464785

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test